OÜ Riisipere Tervisekeskus

10345191

General info

Name

OÜ Riisipere Tervisekeskus

Registry code

10345191

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

16.12.1997 (26)

Financial year

01.01-31.12

Capital

2 556.00 €

Activity

86211 - Provision of general medical treatment

Revenue

413 924 €

Profit

122 983 €

Profit margin

30%

Gross salary

2 510 €

(estimate is approximate)

Equity

562 643 €

Employees

4

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

22%

Return on assets

20%

Related parties

Owner Representative Beneficial owner Roles

Ene Arro

16.06.1954 (70)

100% - 2 556.00 EUR Board member Direct ownership Founder

Financial info

2019
05.08.2020
2020
19.06.2021
2021
22.06.2022
2022
28.06.2023
2023
30.06.2024
Total Revenue 175 326 € 180 534 € 209 597 € 292 796 € 413 924 €
Net profit (loss) for the period 84 546 € 114 859 € 102 243 € 28 551 € 122 983 €
Profit Margin 48% 64% 49% 10% 30%
Current Assets 150 875 € 108 302 € 186 467 € 209 577 € 276 481 €
Fixed Assets 204 065 € 319 336 € 312 799 € 306 260 € 323 979 €
Total Assets 354 940 € 427 638 € 499 266 € 515 837 € 600 460 €
Current Liabilities 20 934 € 13 773 € 18 157 € 41 177 € 37 817 €
Non Current Liabilities 0 € 0 € 0 € 0 € 0 €
Total Liabilities - - - - -
Share Capital - - - - -
Equity 334 006 € 413 865 € 481 109 € 474 660 € 562 643 €
Employees 2 1 2 3 4

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 - 20 988.46 € 20 362.22 € 4
2023 Q4 - 16 747.32 € 16 402.59 € 4
2023 Q3 - 16 679.07 € 16 402.59 € 4
2023 Q2 - 17 836.69 € 16 148.29 € 4
2023 Q1 - 16 084.17 € 15 374.61 € 5
2022 Q4 - 16 107.52 € 16 052.49 € 5
2022 Q3 - 16 559.56 € 15 796 € 5
2022 Q2 - 11 577.73 € 11 270.75 € 5
2022 Q1 - 12 070.48 € 11 046.8 € 4
2021 Q4 - 6 676.07 € 3 566.79 € 3
2021 Q3 - 11 208.15 € 10 076.54 € 3
2021 Q2 - 5 372.18 € 4 583.76 € 3
2021 Q1 - 5 489.39 € 4 194.57 € 3
2020 Q4 - 6 726.38 € 2 768.04 € 3
2020 Q3 - 4 299.99 € 2 977.11 € 3
2020 Q2 - 5 131.71 € 3 502.33 € 3
2020 Q1 - 8 136.79 € 7 354.89 € 3